Hormones and longevity: menopause, optimization and where experts draw lines
September 27, 2026 · 17 min read
Mosconi links menopause to women's Alzheimer's risk, while Attia and Koniver discuss hormone optimization as a longevity lever with differing enthusiasm. Midlife hormone changes turn out to matter well beyond fertility and deserve informed attention.
The rules, numbers and steps worth keeping in front of you.
- Mosconi: menopause is a neurological transition; the steep estrogen drop changes brain function.
- Nearly two-thirds of Alzheimer's patients are women.
- Surgical menopause carries higher dementia risk, especially without supportive therapy (Mosconi).
- Mosconi: hormone therapy helps some women but not all; phytoestrogen foods are a gentler option.
- Attia: estrogen is the key hormone for bone; women's bone mass falls steeply after 50.
- Track bone with DEXA scans and train with heavy loads.
- Attia on the Women's Health Initiative: the breast cancer rise was about four to five cases per thousand women.
- Attia: always ask for absolute risk alongside relative risk.
- Attia uses an estradiol patch plus micronized progesterone; oral estrogen raises clotting risk.
- Men: measure free testosterone, SHBG and estradiol, not just total testosterone.
- Attia and Koniver both avoid pellets; young men should fix sleep, training and nutrition first.
- Direct hormones can shut down the body's own production and fertility.
- Koniver: use a physician and a regulated compounding pharmacy, never gray-market research peptides.
- Make hormone decisions with a physician experienced in hormone care.
This is the short form. The full insight has every expert's reasoning, their own words and the sources.